Free Trial

Teamwork Financial Advisors LLC Purchases New Holdings in UiPath, Inc. $PATH

UiPath logo with Computer and Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Teamwork Financial Advisors LLC established a new position in UiPath (NYSE:PATH), acquiring 108,676 shares in Q4 valued at approximately $1,781,000.
  • UiPath beat the quarter with $0.30 EPS vs. $0.25 expected and revenue of $481.11 million (+13.4% YoY), but several analysts trimmed price targets and the consensus rating is Hold with an average target of $14.07.
  • Company insiders have been net sellers recently—including CEO and CFO sales—and insiders sold 607,468 shares worth about $9.89 million over the last quarter, with insiders owning 23.19% of the stock.
  • Five stocks we like better than UiPath.

Teamwork Financial Advisors LLC acquired a new position in UiPath, Inc. (NYSE:PATH - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 108,676 shares of the company's stock, valued at approximately $1,781,000.

Other institutional investors have also added to or reduced their stakes in the company. Noble Wealth Management PBC bought a new position in shares of UiPath during the fourth quarter valued at approximately $25,000. Twin Peaks Wealth Advisors LLC bought a new stake in shares of UiPath during the 2nd quarter worth approximately $28,000. GAMMA Investing LLC boosted its holdings in UiPath by 93.3% during the 4th quarter. GAMMA Investing LLC now owns 5,251 shares of the company's stock valued at $86,000 after acquiring an additional 2,534 shares during the period. Covestor Ltd boosted its holdings in UiPath by 17.7% during the 3rd quarter. Covestor Ltd now owns 6,522 shares of the company's stock valued at $87,000 after acquiring an additional 981 shares during the period. Finally, CX Institutional grew its position in UiPath by 37.4% in the 3rd quarter. CX Institutional now owns 6,888 shares of the company's stock valued at $92,000 after acquiring an additional 1,874 shares during the last quarter. Institutional investors own 62.50% of the company's stock.

Analyst Upgrades and Downgrades

PATH has been the topic of a number of recent analyst reports. Mizuho reduced their target price on UiPath from $15.00 to $12.00 and set a "neutral" rating on the stock in a research note on Thursday, March 12th. BMO Capital Markets cut their price target on shares of UiPath from $17.00 to $14.00 and set a "market perform" rating on the stock in a report on Friday, March 13th. Truist Financial reduced their price target on shares of UiPath from $17.00 to $12.00 and set a "hold" rating on the stock in a research note on Thursday, March 12th. UBS Group decreased their price objective on shares of UiPath from $17.00 to $13.00 and set a "neutral" rating for the company in a report on Thursday, March 12th. Finally, Canaccord Genuity Group lowered their price objective on shares of UiPath from $19.00 to $15.00 and set a "buy" rating for the company in a research report on Thursday, March 12th. Three equities research analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $14.07.

Get Our Latest Stock Report on UiPath

Insider Activity

In other UiPath news, CEO Daniel Dines sold 45,000 shares of the stock in a transaction dated Wednesday, January 14th. The shares were sold at an average price of $15.68, for a total transaction of $705,600.00. Following the transaction, the chief executive officer directly owned 28,028,585 shares in the company, valued at $439,488,212.80. This represents a 0.16% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Ashim Gupta sold 67,468 shares of the firm's stock in a transaction dated Monday, January 5th. The shares were sold at an average price of $16.10, for a total transaction of $1,086,234.80. Following the transaction, the chief financial officer directly owned 557,028 shares in the company, valued at $8,968,150.80. This trade represents a 10.80% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 607,468 shares of company stock worth $9,893,635. 23.19% of the stock is owned by company insiders.

UiPath Stock Down 1.5%

PATH opened at $12.06 on Monday. The stock's fifty day moving average is $12.49 and its two-hundred day moving average is $14.06. The company has a market capitalization of $6.45 billion, a P/E ratio of 23.19, a PEG ratio of 1.97 and a beta of 1.09. UiPath, Inc. has a 52 week low of $9.38 and a 52 week high of $19.84.

UiPath (NYSE:PATH - Get Free Report) last posted its quarterly earnings results on Wednesday, March 11th. The company reported $0.30 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.25 by $0.05. The business had revenue of $481.11 million for the quarter, compared to the consensus estimate of $464.81 million. UiPath had a return on equity of 5.69% and a net margin of 17.53%.The business's revenue was up 13.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.26 EPS. Equities analysts anticipate that UiPath, Inc. will post -0.17 earnings per share for the current year.

About UiPath

(Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric.

Recommended Stories

Institutional Ownership by Quarter for UiPath (NYSE:PATH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in UiPath Right Now?

Before you consider UiPath, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.

While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines